For instance, high titers of anti-CA I autoantibodies were observed in sera of patients with Hodgkin's disease, multiple myeloma, and some other hemato-oncological malignancies after high-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) [29]. The gene discussed is CA1; the disease is AL amyloidosis.